Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

A CAR-NKT cell therapy targets cancer through multiple pathways, showing complete tumor elimination in preclinical models. The off-the-shelf platform reduces costs, improves access, and the therapy ...

Menopause is a natural life stage, however, it brings hormonal shifts that may influence cancer risk. Oncologist says awareness, screening and positive lifestyle choices help women over 45 to protect ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...

To resist authoritarianism, our work must be deeply relational. We must act even in uncertainty. Nurturing builds power.

Belvoir Farm, pronounced beaver, has announced a new partnership with the Lady Garden Foundation, a national women’s health ...

AstraZeneca AZN announced that the European Commission (EC) has approved its blockbuster cancer drug Imfinzi (durvalumab) as a perioperative treatment for early gastric and gastroesophageal junction ...

Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for ...

KATHMANDU, March 17: The Kathmandu Metropolitan City (KMC) and Bir Hospital have signed an agreement to provide free testing and preliminary treatment for breast and uterine cancers. The agreement was ...